ATE305926T1 - Pyridazin-3-on-derivate und sie enthaltende medikamente - Google Patents

Pyridazin-3-on-derivate und sie enthaltende medikamente

Info

Publication number
ATE305926T1
ATE305926T1 AT00905344T AT00905344T ATE305926T1 AT E305926 T1 ATE305926 T1 AT E305926T1 AT 00905344 T AT00905344 T AT 00905344T AT 00905344 T AT00905344 T AT 00905344T AT E305926 T1 ATE305926 T1 AT E305926T1
Authority
AT
Austria
Prior art keywords
group
substituted
unsubstituted
derivatives
pyridazine
Prior art date
Application number
AT00905344T
Other languages
English (en)
Inventor
Masao Ohkuchi
Yoshinori Kyotani
Hiromichi Shigyo
Hideo Yoshizaki
Tomoyuki Koshi
Takahiro Kitamura
Takayuki Matsuda
Kyoko Yasuoka
Tomoko Furuyama
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE305926T1 publication Critical patent/ATE305926T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00905344T 1999-02-26 2000-02-25 Pyridazin-3-on-derivate und sie enthaltende medikamente ATE305926T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11049758A JP2000247959A (ja) 1999-02-26 1999-02-26 ピリダジン−3−オン誘導体及びこれを含有する医薬
PCT/JP2000/001098 WO2000050408A1 (fr) 1999-02-26 2000-02-25 Derives de pyridazin-3-one et medicaments contenant ces derives

Publications (1)

Publication Number Publication Date
ATE305926T1 true ATE305926T1 (de) 2005-10-15

Family

ID=12840099

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905344T ATE305926T1 (de) 1999-02-26 2000-02-25 Pyridazin-3-on-derivate und sie enthaltende medikamente

Country Status (18)

Country Link
US (1) US6680316B1 (de)
EP (1) EP1156039B1 (de)
JP (2) JP2000247959A (de)
KR (1) KR100647726B1 (de)
CN (1) CN1148355C (de)
AT (1) ATE305926T1 (de)
AU (1) AU764393B2 (de)
CA (1) CA2364801C (de)
DE (1) DE60022986T2 (de)
DK (1) DK1156039T3 (de)
ES (1) ES2250100T3 (de)
HK (1) HK1044534B (de)
HU (1) HUP0200088A3 (de)
NO (1) NO319832B1 (de)
NZ (1) NZ513578A (de)
RU (1) RU2232755C2 (de)
TW (1) TWI249533B (de)
WO (1) WO2000050408A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1142148C (zh) * 1997-11-19 2004-03-17 兴和株式会社 新颖的哒嗪衍生物和含有其作为有效成分的药物
ATE425148T1 (de) * 2000-09-18 2009-03-15 Eisai R&D Man Co Ltd Triazinone sowie deren medizinale anwendung
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
KR20040039377A (ko) * 2001-09-26 2004-05-10 코와 가부시키가이샤 수용성 페닐피리다진 유도체 및 이를 함유하는 의약
WO2004078751A1 (ja) * 2003-03-07 2004-09-16 Kowa Co., Ltd. ベンゾフラン誘導体
CN1759103A (zh) * 2003-03-18 2006-04-12 兴和株式会社 水溶性苯基哒嗪衍生物及含有该衍生物的医药品
EP1628665A2 (de) * 2003-04-16 2006-03-01 Amgen Inc. 3-phenyl-4-(pyrimidin-2-yl)-6-(piperidin-4-yl) derivate und verwandte verbindungen als tnf-alpha und il-1 inhibitoren zur behandlung von entzündlichen erkrankungen
WO2007044796A2 (en) * 2005-10-11 2007-04-19 Nps Pharmaceuticals, Inc. Pyridazinone compounds as calcilytics
JPWO2007049732A1 (ja) * 2005-10-28 2009-04-30 興和株式会社 関節リウマチの予防及び/又は治療法
EP2953944B1 (de) * 2013-02-07 2017-04-26 Merck Patent GmbH Pyridazinonamidderivate
MX2017009624A (es) * 2015-02-06 2017-11-20 Merck Patent Gmbh Macrociclos de piridazinona como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos.
FR3103701B1 (fr) * 2019-11-28 2021-11-26 Inst Nat Sante Rech Med Composés de typen2-arylméthyl-4-haloalkyl-pyridazin-3-one et leur utilisation
UY39082A (es) * 2020-02-14 2021-09-30 Fmc Corp Piridazinonas fungicidas

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2839532A (en) * 1958-06-17 Pyridazone compounds and process of
GB788393A (en) * 1953-04-30 1958-01-02 Ciba Ltd Process for the manufacture of pyridazone compounds
US3840597A (en) 1971-02-24 1974-10-08 Riker Laboratories Inc Substituted 2-phenoxy alkane-sulfonanilides
AR206496A1 (es) 1972-07-03 1976-07-30 Riker Laboratories Inc Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas
US4238490A (en) * 1979-02-12 1980-12-09 Diamond Shamrock Corporation Antihypertensive pyridazin(2H)-3-ones
JPS57501328A (de) * 1980-08-07 1982-07-29
US4545810A (en) 1980-08-07 1985-10-08 Sds Biotech Corporation Herbicidal and plant growth regulant diphenylpyridazinones
JPH0753725B2 (ja) 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
FI91062C (fi) 1988-12-28 1994-05-10 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisten naftaleenijohdannaisten valmistamiseksi
MX9300141A (es) 1992-01-13 1994-07-29 Smithkline Beecham Corp Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
DE69408598T2 (de) * 1993-06-08 1998-09-17 Vertex Pharmaceuticals Inc Cam Pyridazine als Interleukin-1-beta Verwandlungsenzym Inhibitoren
EP0871444A4 (de) 1995-08-10 1999-01-13 Merck & Co Inc 2,5 substituierte aryl pyrrol, dieses enthaltende zusammensetzungen und dessen verwendung
CA2294548A1 (en) 1997-08-22 1999-03-04 Abbott Laboratories Pyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
WO1999010331A1 (en) 1997-08-22 1999-03-04 Abbott Laboratories Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
CN1142148C (zh) 1997-11-19 2004-03-17 兴和株式会社 新颖的哒嗪衍生物和含有其作为有效成分的药物
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
CN1279026C (zh) 1998-10-27 2006-10-11 艾博特公司 前列腺素内过氧化物h合酶生物合成抑制剂

Also Published As

Publication number Publication date
CA2364801C (en) 2009-05-19
NO20014099D0 (no) 2001-08-23
AU764393B2 (en) 2003-08-14
TWI249533B (en) 2006-02-21
NZ513578A (en) 2005-04-29
HK1044534A1 (en) 2002-10-25
WO2000050408A1 (fr) 2000-08-31
NO20014099L (no) 2001-10-23
US6680316B1 (en) 2004-01-20
HUP0200088A2 (hu) 2002-11-28
DE60022986T2 (de) 2006-05-11
CA2364801A1 (en) 2000-08-31
ES2250100T3 (es) 2006-04-16
EP1156039B1 (de) 2005-10-05
DE60022986D1 (de) 2006-02-16
JP2000247959A (ja) 2000-09-12
CN1148355C (zh) 2004-05-05
CN1341103A (zh) 2002-03-20
KR100647726B1 (ko) 2006-11-23
HUP0200088A3 (en) 2002-12-28
EP1156039A4 (de) 2002-04-17
NO319832B1 (no) 2005-09-19
AU2692800A (en) 2000-09-14
HK1044534B (zh) 2004-12-10
DK1156039T3 (da) 2006-01-30
RU2232755C2 (ru) 2004-07-20
JP4456765B2 (ja) 2010-04-28
EP1156039A1 (de) 2001-11-21
KR20010101979A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
ATE305926T1 (de) Pyridazin-3-on-derivate und sie enthaltende medikamente
ATE193828T1 (de) Hypoglykämische dihydrochalconderivate
DK490288A (da) Substituerede thiazolidindionderivater
KR987000261A (ko) 벤즈아미드옥심 유도체, 그의 제법 및 농원예용 살균제 (Benzamidoxime Derivative, Proecss for Production Thereof,and Agrohorticultural Bactericide)
DE60130119D1 (de) Phenylpyridazinderivate und diese enthaltende arzneimittel
ATE428700T1 (de) Pyridazinderivate und diese als aktiven bestandteil enthaltende medikamente
DE60118225D1 (de) Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
DE69935718D1 (de) Antidiabetische medikamente
DE60117847D1 (de) Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate
IE821337L (en) Mandelic acid derivatives and mandelonitriles.
CA2011087A1 (en) Use of trifluoromethylphenylazolylmethyloxiranes as crop protection agents
ATE74608T1 (de) Chinolincarbonsaeure-derivate.
NO903335L (no) Substituerte aminoalkoksy-benzolderivater.
EP1182192A4 (de) 4-hydroxypiperidin-derivate mit antiarrhythmischem effekt
AU2318600A (en) Chondrongenesis promotors and indolin-2-one derivatives
ATE219065T1 (de) Arylpiperidin- und arylpiperazin-derivate und sie enthaltende arzneimittel
RU94037965A (ru) Производные бензоксазола в виде рацемата или отдельных энантиомеров и их фармацевтически приемлемые соли и фармацевтические композиции с ингибирующей биосинтез лейкотриенов активностью
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
ATE121073T1 (de) Herbizide acrylonitrilderivate.
KR890012973A (ko) 이미다졸 유도체
IL92646A0 (en) Imidazolyl and pyridyl derivatives of phenyl substituted 1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
ATE318265T1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
DE69018741D1 (de) Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre.
DE69106235D1 (de) N-Oxyimidsäurederivate.
PT816355E (pt) Derivados espiro-heterociclicos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1156039

Country of ref document: EP

REN Ceased due to non-payment of the annual fee